Why Perform H. pylori Testing?
H. pylori testing should be performed because this infection causes peptic ulcer disease, chronic gastritis, and is classified as a Class I carcinogen strongly associated with gastric malignancies, making diagnosis essential for preventing serious morbidity and mortality. 1
Primary Reasons for Testing
Disease Prevention and Treatment
H. pylori is one of the most common chronic infections in humans and directly causes:
- Peptic ulcer disease - Testing and eradication cures underlying ulcers and prevents recurrence
- Gastric cancer - The infection initiates and maintains the inflammatory pathway leading to atrophic gastritis, metaplasia, and ultimately invasive carcinoma 2
- Chronic gastritis - Universal in infected individuals
- MALT lymphoma - H. pylori-associated gastric lymphomas 3
Specific Clinical Scenarios Requiring Testing
Test all patients with bleeding peptic ulcer - H. pylori eradication significantly reduces ulcer recurrence and rebleeding rates (from 26% to minimal rates). 4
Young dyspeptic patients (<50 years) - The "test-and-treat" strategy is safe, reduces endoscopy needs by 62%, and is cost-effective in primary care for uninvestigated dyspepsia without alarm symptoms. 1
Documented peptic ulcer disease - All patients with active or past ulcers require testing, as eradication prevents recurrence. 3, 5
Gastric cancer prevention - Testing is recommended for patients with precancerous gastric lesions, family history of gastric cancer, or those at higher risk. Eradication halts the exponential increase in cancer risk with age. 2, 6
Testing Strategy Advantages
Non-Invasive Approach
Non-invasive testing avoids endoscopy, which is expensive, unpleasant, and carries definite complication risks. 1 The preferred non-invasive tests are:
- Urea breath test (UBT) - Sensitivity 94.7%, specificity 95.7% 1
- Stool antigen test - Sensitivity 94%, specificity 92% 4
These tests identify active infection and are suitable for initial diagnosis and post-treatment confirmation.
Economic and Clinical Efficiency
The test-and-treat strategy will:
- Cure most underlying peptic ulcer disease
- Prevent most potential gastroduodenal disease cases
- Provide symptomatic benefit in functional dyspepsia patients 7
- Reduce healthcare costs compared to empiric endoscopy 1
Critical Testing Considerations
Stop PPIs 2 weeks before testing - Proton pump inhibitors cause 10-40% false-negative results by decreasing bacterial load. If stopping PPIs is impossible, use serology instead. 8
Confirm eradication after treatment - Post-treatment testing is essential for patients with peptic ulcer disease, persistent symptoms, MALT lymphoma, or after gastric cancer resection. 3
Antibiotic susceptibility matters - In regions with high clarithromycin resistance (≥15%), culture and susceptibility testing should be considered before first-line treatment when endoscopy is performed. 8
Common Pitfalls to Avoid
Don't use serology alone for diagnosis - Antibodies persist long after eradication, leading to false positives as more patients receive treatment. Serology sensitivity/specificity averages only 85%/79%. 1
Don't test when pre-test probability is extreme - Below 20% probability, positive results are unreliable; above 80%, negative results are unreliable. 9
Don't skip testing in bleeding ulcers - Despite the acute setting, all bleeding peptic ulcer patients should undergo H. pylori testing, as eradication is the definitive prevention for rebleeding. 4
The fundamental principle: "The only good H. pylori is a dead H. pylori" - testing enables eradication, which prevents progression to life-threatening complications including gastric cancer. 7